candesartan has been researched along with Necrosis in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sherif, IO | 1 |
| Sarhan, OM | 1 |
| Matsumoto, N | 1 |
| Manabe, H | 1 |
| Ochiai, J | 1 |
| Fujita, N | 1 |
| Takagi, T | 1 |
| Uemura, M | 1 |
| Naito, Y | 1 |
| Yoshida, N | 1 |
| Oka, S | 1 |
| Yoshikawa, T | 1 |
2 other studies available for candesartan and Necrosis
| Article | Year |
|---|---|
Candesartan in a rat model of testicular toxicity: New insight on its protective mechanism.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Benzimidazoles; Biphenyl Compou | 2019 |
An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Apoptosis; | 2003 |